Eden Prairie, MN – According to filings with the U.S. Securities and Exchange Commission, RxFunction is raising $4,290,592.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Mary Anderson played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About RxFunction

RxFunction is a medical device company with a mission to design and market medical technologies that restore balance, increase mobility, and enhance confidence for patients at risk of falling. RxFunction created Walkasins external lower limb sensory neuroprosthesis, building upon patented technology developed by co-founder and scientist Lars Oddsson, PhD. Development of Walkasins was supported by Small Business Innovation Research grants from the National Institutes of Health and the product is manufactured in Minnesota.

To learn more about RxFunction, visit http://rxfunction.com/

Contact:
Mary Anderson, Chief Executive Officer
888-382-3518
mary.anderson@rxfunction.com
https://www.linkedin.com/in/mary-ernst-anderson-32202714a/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved